Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
IRX5183 is an agonist of retinoic acid receptor alpha (RARalpha), which increases RARalpha signaling, potentially resulting in increased apoptosis and differentiation and decreased proliferation of tumor cells (NCI Drug Dictionary).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|